<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03448315</url>
  </required_header>
  <id_info>
    <org_study_id>405</org_study_id>
    <nct_id>NCT03448315</nct_id>
  </id_info>
  <brief_title>Role of Transcrainal Direct Current Brain Stimulation in Acute and Chronic Post-mastectomy Pain Management</brief_title>
  <official_title>Role of Transcrainal Direct Current Brain Stimulation in Acute and Chronic Post-mastectomy Pain Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the role of transcranial magnetic stimulation over the primary motor cortex area on acute
      postoperative pain after breast cancer surgery and on the probability of developing chronic
      neuropathic pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New analgesic strategies are needed that can be used adjunctively to existing strategies with
      the potential to reduce reliance on opioid analgesia. Several novel brain stimulation
      technologies including transcranial direct current stimulation (tDCS) are beginning to
      demonstrate promise as treatments for a variety of pain conditions. Electricity has no
      metabolite or other residue, and can be delivered with minimal discomfort and without
      problems associated with drug-drug interactions.Transcranial direct current stimulation has
      been studied in patients with various disorders and multiple pain syndromes. There is also
      evidence that tDCS might be useful in postsurgical pain reduction.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total morphine comsuption</measure>
    <time_frame>48 hours</time_frame>
    <description>the total dose of morphine used as analgesic expressed in mg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>baseline,at 2,4,6, 12, 24,36,48 hours</time_frame>
    <description>patient asked to describe this pain with scores ranging from 0 to10 (with 0 = no pain and 10 = the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Douleur Neuropathique 4 questions DN4</measure>
    <time_frame>1month, 3month, 6 month</time_frame>
    <description>the possibility of development of neuropathic pain will be assessed using DN4 scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions) but stimulation device is turned off without the participant knowledge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>motor cortex stimulation (2 mA, 20 min for 4 sessions)</description>
    <arm_group_label>real tDCS</arm_group_label>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II, scheduled for unilateral modified radical mastectomy with axillary
             dissection for breast cancer

        Exclusion Criteria:

          -  patients with intracranial metallic devices or with pacemakers or any other device.

          -  patients with Neurological or psychiatric disorders,

          -  patients taking major centrally acting drugs (antiepileptics or antidepressants),
             -opioid dependence,

          -  substance abuse,

          -  severe cardiopulmonary, renal, hepatic diseases, and

          -  those with extensive myocardial ischemia or unstable angina.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>South Egypt Cancer Institute</name>
      <address>
        <city>Assiut</city>
        <zip>11715</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>June 27, 2019</last_update_submitted>
  <last_update_submitted_qc>June 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shereen Mamdouh</investigator_full_name>
    <investigator_title>Lectruer of anesthesia, ICU and pain manegement</investigator_title>
  </responsible_party>
  <keyword>brain stimulation, tDCS, acute postoperative pain, chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

